Research Article

Intramuscular meperidine analgesia at the beginning of active phase shortens labor duration without adverse effects on obstetric lacerations and neonatal outcomes

Volume: 38 Number: 4 October 9, 2021
EN

Intramuscular meperidine analgesia at the beginning of active phase shortens labor duration without adverse effects on obstetric lacerations and neonatal outcomes

Abstract

Objective: The primary objectives of this study were to evaluate the impact of intramuscular meperidine on shortening of the active phase of labor, the neonatal outcome and the rate and severity of perineal lacerations in term pregnant women in the first stage of labor. Materials and Methods: A total of 571 primiparous term pregnant women delivered vaginally were included into this retrospective study. In 437 of them, meperidine (100 mg IM) at the beginning of the active phase was administered and 134 women did not receive any meperidine dose. The length of labor phases, obstetric lacerations, and neonatal outcomes were recorded. Results: The results of this study showed that meperidine could be used safely as an obstetric analgesic with its additional benefit of shortening the active phase of the first stage and second stage of labor without increased risk of obstetric lacerations and perinatal adverse outcomes. Conclusions: In case of limited use of neuroaxil analgesia in a busy state maternity hospital, intramuscular meperidine administration as obstetric analgesia seems beneficial in reducing the length of the active phase of the first stage of labor and the second stage of labor without adversely affecting obstetric lacerations and neonatal outcomes.

Keywords

References

  1. Aburel E. L'anesthésie locale continue (prolongée) en obstétrique. Bull Soc Obstet Gynecol 1931; 20: 35-37.
  2. ACOG Committee Opinion 295: pain relief during labor. Obstet Gynecol. 2004; 104: 213.
  3. Allman KG, Wilson H, and O’Donnel A. Chapter 41 Regional anaesthesia. In: Oxford Handbook of Anaesthesia. 2006: 1120.
  4. Berghella V, Baxter JK, Chauhan SP. Evidence-based labor and delivery management. Am J Obstet Gynecol. 2008; 199: 445-454.
  5. Caton D. The History of Obstetric Anesthesia. In: Chestnut’s Obstetric Anesthesia: Principles and Practice. 2009; 114: 1326–1331.
  6. Kominiarek MA, Zhang J, VanVeldhuisen P, Troendle J, Beaver J, Hibbard JU. Contemporary labor patterns: the impact of maternal body mass index. Am J Obstet Gynecol. 2011; 205: 244-244.
  7. Lang AJ, Sorrell JT, Rodgers CS, Lebeck MM. Anxiety sensitivity as a predictor of labor pain. Eur J Pain. 2006; 10: 263-70.
  8. Latta KS, Ginsberg B, Barkin RL. Meperidine: A Critical Review. Am J Ther . 2002; 9: 53-68.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

October 9, 2021

Submission Date

February 25, 2021

Acceptance Date

March 14, 2021

Published in Issue

Year 2021 Volume: 38 Number: 4

APA
Güçlü, M., Yurtcu, N., Çelik, S., Soyer Çalışkan, C., Hatırnaz, Ş., & Çelik, H. (2021). Intramuscular meperidine analgesia at the beginning of active phase shortens labor duration without adverse effects on obstetric lacerations and neonatal outcomes. Deneysel Ve Klinik Tıp Dergisi, 38(4), 594-598. https://izlik.org/JA88HR33JP
AMA
1.Güçlü M, Yurtcu N, Çelik S, Soyer Çalışkan C, Hatırnaz Ş, Çelik H. Intramuscular meperidine analgesia at the beginning of active phase shortens labor duration without adverse effects on obstetric lacerations and neonatal outcomes. J. Exp. Clin. Med. 2021;38(4):594-598. https://izlik.org/JA88HR33JP
Chicago
Güçlü, Mehmet, Nazan Yurtcu, Samettin Çelik, Canan Soyer Çalışkan, Şafak Hatırnaz, and Handan Çelik. 2021. “Intramuscular Meperidine Analgesia at the Beginning of Active Phase Shortens Labor Duration Without Adverse Effects on Obstetric Lacerations and Neonatal Outcomes”. Deneysel Ve Klinik Tıp Dergisi 38 (4): 594-98. https://izlik.org/JA88HR33JP.
EndNote
Güçlü M, Yurtcu N, Çelik S, Soyer Çalışkan C, Hatırnaz Ş, Çelik H (October 1, 2021) Intramuscular meperidine analgesia at the beginning of active phase shortens labor duration without adverse effects on obstetric lacerations and neonatal outcomes. Deneysel ve Klinik Tıp Dergisi 38 4 594–598.
IEEE
[1]M. Güçlü, N. Yurtcu, S. Çelik, C. Soyer Çalışkan, Ş. Hatırnaz, and H. Çelik, “Intramuscular meperidine analgesia at the beginning of active phase shortens labor duration without adverse effects on obstetric lacerations and neonatal outcomes”, J. Exp. Clin. Med., vol. 38, no. 4, pp. 594–598, Oct. 2021, [Online]. Available: https://izlik.org/JA88HR33JP
ISNAD
Güçlü, Mehmet - Yurtcu, Nazan - Çelik, Samettin - Soyer Çalışkan, Canan - Hatırnaz, Şafak - Çelik, Handan. “Intramuscular Meperidine Analgesia at the Beginning of Active Phase Shortens Labor Duration Without Adverse Effects on Obstetric Lacerations and Neonatal Outcomes”. Deneysel ve Klinik Tıp Dergisi 38/4 (October 1, 2021): 594-598. https://izlik.org/JA88HR33JP.
JAMA
1.Güçlü M, Yurtcu N, Çelik S, Soyer Çalışkan C, Hatırnaz Ş, Çelik H. Intramuscular meperidine analgesia at the beginning of active phase shortens labor duration without adverse effects on obstetric lacerations and neonatal outcomes. J. Exp. Clin. Med. 2021;38:594–598.
MLA
Güçlü, Mehmet, et al. “Intramuscular Meperidine Analgesia at the Beginning of Active Phase Shortens Labor Duration Without Adverse Effects on Obstetric Lacerations and Neonatal Outcomes”. Deneysel Ve Klinik Tıp Dergisi, vol. 38, no. 4, Oct. 2021, pp. 594-8, https://izlik.org/JA88HR33JP.
Vancouver
1.Mehmet Güçlü, Nazan Yurtcu, Samettin Çelik, Canan Soyer Çalışkan, Şafak Hatırnaz, Handan Çelik. Intramuscular meperidine analgesia at the beginning of active phase shortens labor duration without adverse effects on obstetric lacerations and neonatal outcomes. J. Exp. Clin. Med. [Internet]. 2021 Oct. 1;38(4):594-8. Available from: https://izlik.org/JA88HR33JP